|

Austrian Left Atrial Appendage Closure Registry

RECRUITINGSponsored by Medical University of Graz
Actively Recruiting
SponsorMedical University of Graz
Started2017-05-16
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03409159

Summary

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who received LAAC in Austria

Exclusion Criteria:

* Absence of informed consent

Conditions3

Atrial FibrillationHeart DiseaseLeft Atrial Appendage Closure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.